DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Reardon DA, Omuro A, Brandes AA. , et al.
Randomized phase 3 study evaluating the efficacy and safety of nivolumab vs bevacizumab in patients with recurrent glioblastoma: Checkmate 143.
Paper presented at: 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS)2017; Zurich, Switzerland
We do not assume any responsibility for the contents of the web pages of other providers.